@article{8315addad7e24315a562c994cc26515b,
title = "Multiple institutional rationalities in the regulation of health technologies: An ethnographic examination",
author = "Mavis Jones and Graham, {Janice E.}",
note = "Funding Information: Mavis Jones is a postdoctoral fellow in the Department of Bioethics at Dalhousie University, Halifax, Canada. The primary focus of her research is health technology governance through networks and institutions, in Europe and in Canada. Her doctoral work (University of East Anglia, UK) was an analysis of UK human genetics policy networks, drawing from theories of public policy and science studies. She currently holds a fellowship from the Canadian Institutes of Health Research which supports her training under medical anthropologist Janice Graham, where she is studying the deployment of evidence and expertise in the regulation of therapeutic product risk. Funding Information: This work is supported by the Canadian Institutes of Health Research from two sources: (1) Dr Janice E Graham{\textquoteright}s project Risk and Regulation of Novel Therapeutic Products (MOP 74473), and (2) Dr Mavis Jones{\textquoteright}s post-doctoral fellowship from the Institute of Genetics (Ethics, Law and Society). Graham first examined the debate surrounding the scientific evaluation of rofecoxib in a public talk, given in Halifax on 23 January 2007, but broadcast nationally through cable networks (Graham, 2007). The authors wish to acknowledge the support of the Canada Research Chairs Program for Dr Graham, and the cooperation of the Biologics and Genetics Therapies Directorate, and the Office of Consumer and Public Involvement, Health Products and Food Branch who participated in this research. They also thank two anonymous referees for helpful comments.",
year = "2009",
month = jul,
doi = "10.3152/030234209X460980",
language = "English",
volume = "36",
pages = "445--455",
journal = "Science and Public Policy",
issn = "0302-3427",
publisher = "Beech Tree Publishing",
number = "6",
}